MedTrace Logo

International Chronic Myeloid Leukemia Pediatric Study

NCT01281735 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2024-01-17

No results posted yet for this study

Summary

The purpose of the study is to describe and characterize CML in a large pediatric cohort of patients.

Conditions

  • Chronic Myeloid Leukemia

Sponsors & Collaborators

  • CIC Inserm 1402

    collaborator UNKNOWN

  • University of Milano Bicocca

    collaborator OTHER

  • University Medical Center Groningen

    collaborator OTHER

  • University of Liege

    collaborator OTHER

  • Imperial College London

    collaborator OTHER

  • University Hospital Dresden

    collaborator OTHER

  • International BFM Study Group

    collaborator NETWORK

  • Poitiers University Hospital

    lead OTHER

Principal Investigators

  • Frederic MILLOT, MD · Poitiers University Hospital

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Australia
  • Austria
  • Belarus
  • Belgium
  • Brazil
  • Chile
  • China
  • Croatia
  • Czechia
  • Denmark
  • France
  • Germany
  • Greece
  • Japan
  • Lebanon
  • Netherlands
  • Poland
  • Slovakia
  • Spain
  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01281735 on ClinicalTrials.gov